Literature DB >> 8851685

Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line.

C Ying1, Z Zhang, G Huang, S Q Li, S Y Ying.   

Abstract

Inhibins and activins are members of the transforming growth factor beta (TGF beta) superfamily. Since TGF beta has been shown to be a potent proliferation-inhibiting agent for the pituitary adenocarcinoma cell line, GH3, we determined whether this cell line (a) transcribes mRNAs coding for inhibin/activin subunits (alpha and beta A) and activin receptors I, II, and IIB; and (b) produces inhibin and/or activin proteins. Messenger RNAs for the alpha- and beta A-subunits of inhibin and activin receptors I, II, and IIB in GH3 cells were detected and localized using the reverse transcription-polymerase chain reaction (RT-PCR) analysis and in situ hybridization, respectively. The identity of the RT-PCR products was confirmed by DNA sequencing of PCR products. Immunocytochemically, inhibin and activin were localized in these cells. Our findings indicate that messenger RNAs encoding inhibin alpha- and beta A-subunits and activin receptors I, II, and IIB were expressed, and inhibin/activin proteins were produced, by GH3 cells, imply that these gonadal growth factors may have paracrine/autocrine functions in rat pituitary adenocarcinoma. Further, these observation suggest that these growth factors may be involved in regulating the growth and differentiational of rat pituitary adenocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851685     DOI: 10.1007/BF03347851

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Inhibition of growth hormone secretion by activin A in human growth hormone-secreting tumour cells.

Authors:  M Kitaoka; K Takano; Y Tanaka; I Kojima; A Teramoto; E Ogata
Journal:  Acta Endocrinol (Copenh)       Date:  1991-06

2.  Evidence for an autocrine role of activin B within rat anterior pituitary cultures.

Authors:  A Z Corrigan; L M Bilezikjian; R S Carroll; L N Bald; C H Schmelzer; B M Fendly; A J Mason; W W Chin; R H Schwall; W Vale
Journal:  Endocrinology       Date:  1991-03       Impact factor: 4.736

3.  Regulation of Leydig cell function in primary culture by inhibin and activin.

Authors:  T Lin; J K Calkins; P L Morris; W Vale; C W Bardin
Journal:  Endocrinology       Date:  1989-10       Impact factor: 4.736

4.  Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.

Authors:  N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; R Guillemin
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

5.  Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins.

Authors:  F S Esch; S Shimasaki; K Cooksey; M Mercado; A J Mason; S Y Ying; N Ueno; N Ling
Journal:  Mol Endocrinol       Date:  1987-05

6.  The TGF-beta family of growth and differentiation factors.

Authors:  J Massagué
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

7.  Growth in suspension culture of rat pituitary cells which produce growth hormone and prolactin.

Authors:  F C Bancroft; A H Tashjian
Journal:  Exp Cell Res       Date:  1971-01       Impact factor: 3.905

8.  Activin-A modulates growth hormone secretion from cultures of rat anterior pituitary cells.

Authors:  L M Bilezikjian; A Z Corrigan; W Vale
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

9.  Activin-binding protein is present in pituitary.

Authors:  K Kogawa; T Nakamura; K Sugino; K Takio; K Titani; H Sugino
Journal:  Endocrinology       Date:  1991-03       Impact factor: 4.736

10.  Inhibition of prolactin gene transcription by transforming growth factor-beta in GH3 cells.

Authors:  B C Delidow; W M Billis; P Agarwal; B A White
Journal:  Mol Endocrinol       Date:  1991-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.